Logo image of HOMI.BR

HOME INVEST BELGIUM (HOMI.BR) Stock Fundamental Analysis

EBR:HOMI - Euronext Brussels - BE0974409410 - REIT - Currency: EUR

18.22  +0.42 (+2.36%)

Fundamental Rating

4

HOMI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 7 industry peers in the Residential REITs industry. While HOMI has a great profitability rating, there are quite some concerns on its financial health. HOMI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year HOMI was profitable.
In the past year HOMI had a positive cash flow from operations.
HOMI had positive earnings in 4 of the past 5 years.
HOMI had a positive operating cash flow in each of the past 5 years.
HOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFHOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

1.2 Ratios

HOMI's Return On Assets of 7.14% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
HOMI's Return On Equity of 13.37% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
HOMI has a Return On Invested Capital of 2.34%. This is comparable to the rest of the industry: HOMI outperforms 42.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HOMI is in line with the industry average of 3.94%.
The last Return On Invested Capital (2.34%) for HOMI is above the 3 year average (2.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.14%
ROE 13.37%
ROIC 2.34%
ROA(3y)3.97%
ROA(5y)4.7%
ROE(3y)8.26%
ROE(5y)9.76%
ROIC(3y)2.28%
ROIC(5y)2.2%
HOMI.BR Yearly ROA, ROE, ROICHOMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

The Profit Margin of HOMI (174.79%) is better than 100.00% of its industry peers.
HOMI's Operating Margin of 74.75% is fine compared to the rest of the industry. HOMI outperforms 71.43% of its industry peers.
In the last couple of years the Operating Margin of HOMI has grown nicely.
HOMI has a Gross Margin of 92.09%. This is amongst the best in the industry. HOMI outperforms 85.71% of its industry peers.
HOMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 74.75%
PM (TTM) 174.79%
GM 92.09%
OM growth 3Y2.87%
OM growth 5Y2.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.84%
HOMI.BR Yearly Profit, Operating, Gross MarginsHOMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

3

2. Health

2.1 Basic Checks

HOMI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HOMI has been increased compared to 1 year ago.
HOMI has more shares outstanding than it did 5 years ago.
HOMI has a better debt/assets ratio than last year.
HOMI.BR Yearly Shares OutstandingHOMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
HOMI.BR Yearly Total Debt VS Total AssetsHOMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

HOMI has an Altman-Z score of 0.80. This is a bad value and indicates that HOMI is not financially healthy and even has some risk of bankruptcy.
HOMI has a Altman-Z score of 0.80. This is in the better half of the industry: HOMI outperforms 71.43% of its industry peers.
The Debt to FCF ratio of HOMI is 41.18, which is on the high side as it means it would take HOMI, 41.18 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 41.18, HOMI perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
HOMI has a Debt/Equity ratio of 0.82. This is a neutral value indicating HOMI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.82, HOMI is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 41.18
Altman-Z 0.8
ROIC/WACC0.37
WACC6.26%
HOMI.BR Yearly LT Debt VS Equity VS FCFHOMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.40 indicates that HOMI may have some problems paying its short term obligations.
HOMI's Current ratio of 0.40 is in line compared to the rest of the industry. HOMI outperforms 57.14% of its industry peers.
A Quick Ratio of 0.40 indicates that HOMI may have some problems paying its short term obligations.
HOMI has a Quick ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
HOMI.BR Yearly Current Assets VS Current LiabilitesHOMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

3

3. Growth

3.1 Past

HOMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 293.46%, which is quite impressive.
The Revenue has been growing slightly by 7.21% in the past year.
The Revenue has been growing slightly by 7.46% on average over the past years.
EPS 1Y (TTM)293.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%555.14%
Revenue 1Y (TTM)7.21%
Revenue growth 3Y9.41%
Revenue growth 5Y7.46%
Sales Q2Q%5.94%

3.2 Future

Based on estimates for the next years, HOMI will show a decrease in Earnings Per Share. The EPS will decrease by -8.21% on average per year.
HOMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.44% yearly.
EPS Next Y-33.62%
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%
EPS Next 5Y-8.21%
Revenue Next Year4.17%
Revenue Next 2Y4.84%
Revenue Next 3Y4.53%
Revenue Next 5Y4.44%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HOMI.BR Yearly Revenue VS EstimatesHOMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
HOMI.BR Yearly EPS VS EstimatesHOMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.73, which indicates a rather cheap valuation of HOMI.
Compared to the rest of the industry, the Price/Earnings ratio of HOMI indicates a rather cheap valuation: HOMI is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. HOMI is valued rather cheaply when compared to this.
HOMI is valuated correctly with a Price/Forward Earnings ratio of 15.14.
HOMI's Price/Forward Earnings is on the same level as the industry average.
HOMI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.73
Fwd PE 15.14
HOMI.BR Price Earnings VS Forward Price EarningsHOMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HOMI.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOMI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 38.52
EV/EBITDA 28.05
HOMI.BR Per share dataHOMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

HOMI has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as HOMI's earnings are expected to decrease with -11.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%

0

5. Dividend

5.1 Amount

No dividends for HOMI!.
Industry RankSector Rank
Dividend Yield N/A

HOME INVEST BELGIUM

EBR:HOMI (3/7/2025, 7:00:00 PM)

18.22

+0.42 (+2.36%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-21 2025-05-21
Inst Owners2.96%
Inst Owner ChangeN/A
Ins Owners3.11%
Ins Owner ChangeN/A
Market Cap368.04M
Analysts45.45
Price Target19.55 (7.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.14
Dividend Growth(5Y)-30.71%
DP18.34%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 5.73
Fwd PE 15.14
P/S 10.28
P/FCF 38.52
P/OCF 14.11
P/B 0.79
P/tB 0.79
EV/EBITDA 28.05
EPS(TTM)3.18
EY17.45%
EPS(NY)1.2
Fwd EY6.61%
FCF(TTM)0.47
FCFY2.6%
OCF(TTM)1.29
OCFY7.09%
SpS1.77
BVpS23.18
TBVpS23.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.14%
ROE 13.37%
ROCE 3.13%
ROIC 2.34%
ROICexc 2.36%
ROICexgc 2.36%
OM 74.75%
PM (TTM) 174.79%
GM 92.09%
FCFM 26.68%
ROA(3y)3.97%
ROA(5y)4.7%
ROE(3y)8.26%
ROE(5y)9.76%
ROIC(3y)2.28%
ROIC(5y)2.2%
ROICexc(3y)2.3%
ROICexc(5y)2.22%
ROICexgc(3y)2.3%
ROICexgc(5y)2.22%
ROCE(3y)3.04%
ROCE(5y)2.94%
ROICexcg growth 3Y5.3%
ROICexcg growth 5Y3.29%
ROICexc growth 3Y5.28%
ROICexc growth 5Y3.3%
OM growth 3Y2.87%
OM growth 5Y2.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.26%
GM growth 5Y0.84%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 41.18
Debt/EBITDA 14.28
Cap/Depr 7093.99%
Cap/Sales 46.16%
Interest Coverage 2.47
Cash Conversion 96.61%
Profit Quality 15.27%
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 0.8
F-Score5
WACC6.26%
ROIC/WACC0.37
Cap/Depr(3y)92.91%
Cap/Depr(5y)2757.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)21.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)293.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%555.14%
EPS Next Y-33.62%
EPS Next 2Y-17.65%
EPS Next 3Y-11.16%
EPS Next 5Y-8.21%
Revenue 1Y (TTM)7.21%
Revenue growth 3Y9.41%
Revenue growth 5Y7.46%
Sales Q2Q%5.94%
Revenue Next Year4.17%
Revenue Next 2Y4.84%
Revenue Next 3Y4.53%
Revenue Next 5Y4.44%
EBIT growth 1Y14.85%
EBIT growth 3Y12.55%
EBIT growth 5Y10.25%
EBIT Next Year31.96%
EBIT Next 3Y13.23%
EBIT Next 5YN/A
FCF growth 1Y-61.81%
FCF growth 3Y134.76%
FCF growth 5Y70.33%
OCF growth 1Y2.38%
OCF growth 3Y14.71%
OCF growth 5Y19.8%